Ursodeoxycholic acid upregulates ERK and Akt in the protection of cardiomyocytes against CoCl2
Ursodeoxycholic acid (UDCA) is used to treat liver diseases and demonstrates cardioprotective effects. Accumulation of the plasma membrane sphingolipid sphingomyelin in the heart can lead to atherosclerosis and coronary artery disease. Sphingomyelinases (SMases) break down sphingomyelin, producing c...
Main Authors: | Ab Rahim, S (Author), Hanafi, NI (Author), Hasani, NAH (Author), Kadir, SHSA (Author), Mohamed, AS (Author), Noor, JM (Author), Osman, NJ (Author), Siran, R (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Ursodeoxycholic acid upregulates ERK and Akt in the protection of cardiomyocytes against CoCl2
by: Ab Rahim, S., et al.
Published: (2016) -
Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart
by: Hanafi, NI, et al.
Published: (2018) -
Acid and Neutral Sphingomyelinase Behavior in Radiation-Induced Liver Pyroptosis and in the Protective/Preventive Role of rMnSOD
by: Samuela Cataldi, et al.
Published: (2020-05-01) -
Holotoxin A1 Induces Apoptosis by Activating Acid Sphingomyelinase and Neutral Sphingomyelinase in K562 and Human Primary Leukemia Cells
by: Seong-Hoon Yun, et al.
Published: (2018-04-01) -
Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart
by: Noorul Izzati Hanafi, et al.
Published: (2018-11-01)